Contrafect Corporation (CFRX) Return on Investment ROI from the third quarter of 2023 to third quarter of 2022 and for the year 2023, average high and low, overall ranking from Sep 30 2023 to Sep 30 2022 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Contrafect Corporation  (NASDAQ: CFRX)


Contrafect's ROI from its third quarter of 2023 to the third quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Contrafect's ROI in the third quarter of 2023?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Contrafect Corporation's return on investment (ROI) in its third quarter of 2023

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter
Y / Y Investment Change TTM - - -95.1 % -82.23 % -62.49 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions -5 1 -1 -2 -3
Return On Investment (TTM) - 2454.36 % - - -
CFRX's Overall Ranking # 5090 # 3974 # 4872 # 4973 # 0
Seq. Investment Change TTM - - -77.32 % -51.32 % -40.36 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -24 -36 -46 -65 -60

CFRX Company Profile >> Back to CFRX Roi Comparisons >> See Annual CFRX Return On Investment



Return On Investment CFRX's Ranking
Within: No.
Industry # 491
Sector # 1006
Overall # 5090

Return On Investment Statistics
High Average Low
17.96 %
-1140.81 %
-29985.09 %
(Sep 30 2019)   (Sep 30 2023)







Financial Statements
Contrafect's III. Quarter Investments $ -5 Millions CFRX's Balance sheet
Contrafect's III. Quarter Income $ -5 Millions Quarterly CFRX's Income Statement
CFRX's Income by Division See CFRX's Income by Division


CFRX Annual Return On Investment (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018
Total Investments in Millions -2 52 42 25 27
Y / Y Investment Growth - 23.48 % 68.72 % -7.85 % -40.84 %
Net Income in Millions -65 -20 -28 -13 -38
Y / Y Net Income Growth - - - - -
Annual Return On Investment - -39.02 % -66.88 % -51.28 % -139.18 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CFRX's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CFRX's Competitors
Subscribers only: Roi for Contrafect's Suppliers
Subscribers only: Return On Investment for CFRX's Customers

Other Ratios
CFRX's Roa CFRX's Inventory Turnover Ratio CFRX's Growth Rates CFRX's Dividend Statistics
CFRX's Profitability Ratios CFRX's Asset Turnover Ratio CFRX's Dividend Growth
CFRX's Roe CFRX's Valuation Ratios CFRX's Financial Strength Ratios CFRX's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2023, within Healthcare Sector ROI
Ir med Inc   300.96 %

Date modified: 2026-09-08T15:11:07+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.